Clinical profile of interstitial lung disease in children from Western India

Authors

  • Mounnish Balaji Department of Pediatric Pulmonology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India https://orcid.org/0009-0003-2113-9132
  • Parmarth Chandane Department of Pediatric Pulmonology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India https://orcid.org/0009-0003-2113-9132
  • Avantika Chauhan Department of Pediatric Pulmonology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India
  • Atul Rane Department of Pediatric Pulmonology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India
  • Alpa Bhosale Department of Pediatrics, K J Somaiya Hospital, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20250092

Keywords:

chILD, Infantile ILD, Niemann pick disease, Pulmonary alveolar microlithiasis, Pulmonary alveolar proteinosis, Pulmonary hemosiderosis, Surfactant disorder

Abstract

Background: The epidemiology of interstitial lung disease in children (chILD) remains largely unknown, particularly in developing countries. This study aims to estimate the spectrum of ILD in children in India

Methods: We retrospectively analysed data from consecutive subjects aged 0 to 18 years with interstitial lung diseases (ILD) recorded in the hospital registry at the Paediatric Respiratory Unit of Bai Jerbai Wadia Institute of Child Health from January 2018 to December 2023. We determined the proportion of each ILD subtype among children.

Results: Out of 30 enrolled children, 60% were male. Symptoms began within the first year in 17 (56%) children, predominantly with a dry cough (77%) and dyspnea. Respiratory compromise signs were common, including tachypnea, tachycardia and hypoxemia, with 17% exhibiting clubbing. Chest X-rays showed reticular/reticulonodular patterns (63%) and HRCT revealed ground glass opacities (63%). Lung function tests indicated a restrictive pattern in 33%. Bronchoscopy aided in diagnosing pulmonary alveolar proteinosis, hypersensitive pneumonitis and diffuse alveolar hemorrhage. Genetic analysis (43% cases) identified surfactant protein disorder as the most common (13%). ILD subtypes included pulmonary hemosiderosis (23%), surfactant protein disorder, pulmonary alveolar proteinosis and Langerhans cell histiocytosis (each 13%).

Conclusions: In Western India, Paediatric interstitial lung diseases exhibit a different pattern compared to adults. Pulmonary hemosiderosis spectrum, pulmonary alveolar proteinosis and surfactant protein disorder emerge as the predominant burdens among children.

Metrics

Metrics Loading ...

References

Nathan N, Berdah L, Delestrain C. Interstitial lung diseases in children. La Presse Médicale. 2020;49(2):103909. DOI: https://doi.org/10.1016/j.lpm.2019.06.007

Cunningham S, Jaffe A, Young LR. Children's interstitial and diffuse lung disease. The Lancet Child & Adolescent Health. 2019;3(8):568-77. DOI: https://doi.org/10.1016/S2352-4642(19)30117-8

Laenger FP, Schwerk N, Dingemann J, Welte T, Auber B, Verleden S, et al. Interstitial lung disease in infancy and early childhood: a clinicopathological primer. Europ Resp Rev. 2022;31(163):345-98. DOI: https://doi.org/10.1183/16000617.0251-2021

Clement A, Nathan N, Epaud R, Fauroux B, Corvol H. Interstitial lung diseases in children. Orphanet J Rare Dis. 2010;5:1-24. DOI: https://doi.org/10.1186/1750-1172-5-22

Sankar J, Pillai MS, Jeeva Sankar M, Lodha R, Kabra SK. Clinical profile of interstitial lung disease in Indian children. Indian pediatrics. 2013;50:127-33. DOI: https://doi.org/10.1007/s13312-013-0034-z

Fan LL, Mullen AL, Brugman SM, Inscore SC, Parks DP, White CW. Clinical spectrum of chronic interstitial lung disease in children. The J Pediat. 1992;121(6):867-72. DOI: https://doi.org/10.1016/S0022-3476(05)80330-0

Bennetts, B., Hime, N., Phu, A., et al. (2017). Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: A decade's experience.

Vijayasekaran D, Giridhar S, Gowrishankar NC, Nedunchelian K, Senguttuvan M. Pediatric interstitial lung disease. Indian Pediatr. 2006;43(10):899-903.

Nathan N, Griese M, Michel K, Carlens J, Gilbert C, Emiralioglu N, et al. Diagnostic workup of childhood interstitial lung disease. European Respiratory Review. 2023;32(167):258-76. DOI: https://doi.org/10.1183/16000617.0188-2022

Brody AS, Guillerman RP, Hay TC, Wagner BD, Young LR, Deutsch GH, et al. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. Am J Roentgenol. 2010;194(1):238-44. DOI: https://doi.org/10.2214/AJR.09.2743

Copley SJ, Bush A. Series: Imaging: HRCT of paediatric lung disease. Paed Resp Rev. 2000;1(2):141-7. DOI: https://doi.org/10.1053/prrv.2000.0040

Klusmann M, Owens C. HRCT in paediatric diffuse interstitial lung disease—a review for 2009. Ped Radiol. 2009;39(3):471-81. DOI: https://doi.org/10.1007/s00247-009-1200-2

Godfrey S. Pulmonary hemorrhage/hemoptysis in children. Pediatric Pulmonol. 2004;37(6):476-84. DOI: https://doi.org/10.1002/ppul.20020

de Blic J. Pulmonary alveolar proteinosis in children. Paediatric respiratory reviews. 2004;5(4):316-22. DOI: https://doi.org/10.1016/j.prrv.2004.07.001

Oikonomou A, Prassopoulos P. Mimics in chest disease: interstitial opacities. Insights into imaging. 2013;4:9-27. DOI: https://doi.org/10.1007/s13244-012-0207-7

Griese M, Lorenz E, Hengst M, Schams A, Wesselak T, Rauch D, et al. Surfactant proteins in pediatric interstitial lung disease. Ped Res. 2016;79(1):34-41. DOI: https://doi.org/10.1038/pr.2015.173

Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, et al. International management platform for children’s interstitial lung disease (chILD-EU). Thorax. 2018;73(3):231-9. DOI: https://doi.org/10.1136/thoraxjnl-2017-210519

Nathan N, Borensztajn K, Clement A. Genetic causes and clinical management of pediatric interstitial lung diseases. Curr Op Pulm Med. 2018;24(3):253-9. DOI: https://doi.org/10.1097/MCP.0000000000000471

Nogee LM. Genetics of pediatric interstitial lung disease. Current opinion in Pediat. 2006;18(3):287-92. DOI: https://doi.org/10.1097/01.mop.0000193310.22462.1f

Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, DeMello DE, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. The J Clin investig. 1994;93(4):1860-3. DOI: https://doi.org/10.1172/JCI117173

Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. New England J Med. 2001;344(8):573-9. DOI: https://doi.org/10.1056/NEJM200102223440805

Hadchouel A, Wieland T, Griese M, Baruffini E, Lorenz-Depiereux B, Enaud L, et al. Biallelic mutations of methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on Réunion Island. The Am J of Human Gen. 2015;96(5):826-31. DOI: https://doi.org/10.1016/j.ajhg.2015.03.010

Hildebrandt J, Yalcin E, Bresser HG, Cinel G, Gappa M, Haghighi A, et al. Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2014;9:1-9. DOI: https://doi.org/10.1186/s13023-014-0171-z

Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, et al. Activated STING in a vascular and pulmonary syndrome. New England J Med. 2014;371(6):507-18. DOI: https://doi.org/10.1056/NEJMoa1312625

Bush A, Cunningham S, De Blic J, Barbato A, Clement A, Epaud R, et al. European protocols for the diagnosis and initial treatment of interstitial lung disease in children. Thorax. 2015;70(11):1078-84. DOI: https://doi.org/10.1136/thoraxjnl-2015-207349

Langston C, Patterson K, Dishop MK, Baker P, Chou P, Cool C, et al. A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group. Pediat Develop Pathol. 2006;9(3):173-80. DOI: https://doi.org/10.2350/06-03-0065.1

Fortmann C, Schwerk N, Wetzke M, Schukfeh N, Ure BM, Dingemann J. Diagnostic accuracy and therapeutic relevance of thoracoscopic lung biopsies in children. Ped Pulmonol. 2018;53(7):948-53. DOI: https://doi.org/10.1002/ppul.23999

Downloads

Published

2025-01-27

How to Cite

Balaji, M., Chandane, P., Chauhan, A., Rane, A., & Bhosale, A. (2025). Clinical profile of interstitial lung disease in children from Western India. International Journal of Contemporary Pediatrics, 12(2), 246–253. https://doi.org/10.18203/2349-3291.ijcp20250092

Issue

Section

Original Research Articles